Relationship of androgens to muscle size and bone mineral density in women with polycystic ovary syndrome

被引:40
|
作者
Douchi, T [1 ]
Oki, T [1 ]
Yamasaki, H [1 ]
Kuwahata, R [1 ]
Nakae, M [1 ]
Nagata, Y [1 ]
机构
[1] Kagoshima Univ, Dept Obstet & Gynecol, Fac Med, Kagoshima 8908520, Japan
来源
OBSTETRICS AND GYNECOLOGY | 2001年 / 98卷 / 03期
关键词
D O I
10.1016/S0029-7844(01)01450-8
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
OBJECTIVE: To investigate the relationship of androgens to regional muscle size and bone mineral density (BMD) in women with polycystic ovary syndrome (PCOS). METHODS: Seventy-one amenorrheic and right-side dominant women with PCOS (mean age +/- standard deviation 28.1 +/- 6.7 years) were enrolled. Baseline characteristics included age, height, weight, and body mass index (BMI). Regional BAM and lean mass were measured by whole-body scanning with dual-energy x-ray absorptiometry. Serum levels of testosterone, dehydroepiandrosterone sulfate (DHEAS), and androstenedione were measured by radioimmunoassay. Correlations between regional BMD and variables were investigated using a Pearson correlation test and multiple regression analysis. RESULTS: Serum testosterone levels correlated significantly with lean mass of the left arm, right arm, trunk, left leg, and right leg (r = .34, P < .05 to r = .50, P < .01). Regional lean mass correlated significantly with respective regional BMD (r = .30, P < .05 to r = .68, P < .001). These relationships remained significant after adjusting for age, height, and weight. Serum testosterone levels were not correlated with BAM of the bilateral arms and lumbar spine. Although serum testosterone levels correlated with leg BMD (r = .34, P < .05 to r = .45, P < .01), significance did not persist after adjusting for respective regional lean mass. CONCLUSION: Testosterone influences regional BMD through increasing regional muscle mass in women with polycystic ovary syndrome. (C) 2001 by the American College of Obstetricians and Gynecologists.
引用
收藏
页码:445 / 449
页数:5
相关论文
共 50 条
  • [31] Augmentation of cortical bone mineral density in women with polycystic ovary syndrome: a peripheral quantitative computed tomography (pQCT) study
    Kassanos, D.
    Trakakis, E.
    Baltas, C. S.
    Papakonstantinou, O.
    Simeonidis, G.
    Salamalekis, G.
    Grammatikakis, I.
    Basios, G.
    Labos, G.
    Skarantavos, G.
    Balanika, A.
    HUMAN REPRODUCTION, 2010, 25 (08) : 2107 - 2114
  • [32] Erratum to: Steroidal contraceptive use is associated with lower bone mineral density in polycystic ovary syndrome
    Lisa J. Moran
    R. L. Thomson
    J. D. Buckley
    M. Noakes
    P. M. Clifton
    R. J. Norman
    G. D. Brinkworth
    Endocrine, 2016, 52 : 404 - 404
  • [33] Relationship of androgens with bone markers, growth factors and bone mineral density in young adults with Turner syndrome
    Yigit, S
    Onyirimba, M
    Gendreau, P
    Rubin, K
    PEDIATRIC RESEARCH, 2003, 53 (04) : 138A - 138A
  • [34] Association Between Plasma Adrenomedullin Levels and Bone Mineral Density in Patients with Polycystic Ovary Syndrome
    Ucar, Banu
    Noyan, Volkan
    Yucel, Aykan
    Sagsoz, Nevin
    Caglayan, Osman
    TURKISH JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2005, 2 (04) : 321 - 326
  • [35] Androgens excess and the pathogenesis of polycystic ovary syndrome
    Walters, Kirsty
    CLINICAL ENDOCRINOLOGY, 2018, 89 : 17 - 17
  • [36] BONE DENSITY PATTERN IN ADOLESCENT WOMEN WITH POLYCYSTIC OVARY SYNDROME (PCOS) FROM INDIA
    Ganie, M. A.
    Mullassery, S.
    Chakraborty, S.
    OSTEOPOROSIS INTERNATIONAL, 2016, 27 : S748 - S749
  • [37] Elevated and diagnostic androgens of polycystic ovary syndrome
    Abdelazim, Ibrahim A.
    Alanwar, Ahmed
    AbuFaza, Mohannad
    Amer, Osama O.
    Bekmukhambetov, Yerbol
    Zhurabekovas, Gulmira
    Shikanova, Svetlana
    Karimova, Bakyt
    MENOPAUSE REVIEW-PRZEGLAD MENOPAUZALNY, 2020, 19 (01): : 1 - 5
  • [38] PLASMA ANDROGENS IN PATIENTS WITH POLYCYSTIC OVARY SYNDROME
    HORTON, R
    NEISLER, J
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1968, 28 (04): : 479 - +
  • [39] POLYCYSTIC OVARY SYNDROME - ROLE OF OVARIAN ANDROGENS
    LOUVET, JP
    CONTRACEPTION FERTILITE SEXUALITE, 1984, 12 (11): : 1275 - 1279
  • [40] Genetic risk for the polycystic ovary syndrome, bone mineral density and fractures in women and men: A UK Biobank Mendelian randomisation study
    Deshmukh, Harshal
    Shah, Najeeb
    Papageorgiou, Maria
    Abdalla, Mohammed Altigani
    Lhaf, Fadel
    Aye, Mo
    Sathyapalan, Thozhukat
    BONE, 2022, 155